Dietary supplement marketer Steroid Bazaar was slapped with a warning letter by the Food and Drug Administration (FDA) over products listed for sale on its website that include unapproved new drugs and misbranded drugs that may be harmful to the public and violate federal law. Among the products offered for sale was Nolvadex, which was also offered under its generic name Tamoxifen citrate, a prescription-only medication used to treat metastatic breast cancer and in the reduction of risk of invasive breast cancer following breast surgery and radiation. “Offering this drug on your websites for unapproved use is particularly concerning given ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.